About Galvanize

Galvanize is a biomedical platform company operating at the convergence of engineering, biology, and healthcare delivery, aiming to deliver life-changing solutions to patients and their doctors.

We create Pulsed Electric Field technologies capable of targeting cells involved in disease processes, in ways unparalleled to other devices or drugs.

We study our technologies in well designed clinical trials to ensure safety and efficacy.

We partner with doctors and healthcare systems so that patients can access our therapies.

Learn more about the Galvanize science and technology platform

Galvanize Leadership

Jonathan Waldstreicher, MD
Founder and Chief Executive Officer
BIO
Kevin Taylor
Chief Operating Officer
BIO
Bill Krimsky, MD
Chief Medical Officer
BIO
Name TK
Chief Financial Officer
BIO

Jonathan Waldstreicher, MD

Founder and
Chief Executive Officer

Steve Anheier

Chief Financial Officer

Kevin Taylor

Chief Operating Officer

Deb Sheffield

Chief Regulatory Officer

Bill Green

Senior Vice President, Sales and Marketing

William S. Krimksy, MD, FCCP, DAABIP

Chief Medical Officer

Board of Directors

Doug Godshall

Executive Chairman, Galvanize

Seth Harrison, MD

Founder and Managing Partner, ATP

Anna Batarina, CFA

Partner, ATP

Zhen Su, MD, MBA

CEO, Marengo Therapeutics

Jonathan Waldstreicher, MD

Founder & CEO, Galvanize

Mohit Trikha, PhD

Venture Partner, ATP

Investors

Galvanize was created and incubated by ATP (Apple Tree Partners).

Other investors in Galvanize include Intuitive Surgical, Gilmartin Capital, and T. Rowe Price.